Search Results for: AGRX


In times of uncertainty, most investors either go to bonds or go to defensive and dividend stocks.  So, why on earth is Zacks featuring its "Top 5 Growth Mutual Funds" ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Arch Coal, Editas, FireEye, Generac, NextEra, Under Armour and More

Stocks were looking for direction on Thursday. After a debt ceiling deal was reached on Wednesday, the European Central Bank kept rates flat and maintained an outlook of lower rates ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chipotle, Dick’s, Gentex, HP, Lowe’s, Teva and Many More

Stocks were indicated to open higher on Thursday after Wednesday's sell-off. The markets remain close to all-time highs, and the one theme that has ruled for over half of the ...
Read Full Story »

Agile Therapeutics Tanks on Secondary Offering

Agile Therapeutics Inc. (NASDAQ: AGRX) saw its stock dip early on Thursday after the firm announced a secondary offering. Although the stock is down year to date, it’s actually more ...
Read Full Story »

Top Analyst Upgrades & Downgrades: Boeing, Chipotle, First Solar, Goldman Sachs, IBM, Lockheed Martin, Lululemon, Vertex and Many More

Stocks were indicated to open only slightly higher on Wednesday after a mixed bag of corporate earnings. What investors need to understand is that the major equity indexes remain just ...
Read Full Story »

4 Companies That Destroyed Shareholders Last Week

The S&P 500 and Dow Jones Industrial Average are pushing new highs as we close the first week of trading of 2017. Although the tailwind of the Trump rally has ...
Read Full Story »
Stock Price

DryShips, Agile Therapeutics in Wednesday’s 52-Week Low Club

January 4, 2017: Here are three stocks trading with relatively heavy volume among 17 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by nearly ...
Read Full Story »
Jon's friends

Wednesday’s Top 5 Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few made absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care ...
Read Full Story »
100 dollar bills

Agile Therapeutics Announces Pricing for Secondary Offering

Agile Therapeutics Inc. (NASDAQ: AGRX) fell in Friday’s session despite the broad markets taking off. The reason behind this was that the company just announced the pricing for its secondary ...
Read Full Story »
Pills and tablets

RBC Out With Top Specialty Pharmaceutical Stocks to Buy for 2016

If there was a sector that joined energy in taking a beating in 2015, it was specialty pharmaceuticals. In fact, it never fails, the guilt by association when something goes ...
Read Full Story »

4 Specialty Pharmaceutical Stocks Could Be the Next Takeover Candidates

The deals just keep on coming, and there is no reason to think they stop anytime soon. Just this week Horizon Pharmaceutical made an unsolicited offer for Depomed, and a ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, Envestnet, Pandora, Regeneron, Spectra, Travelers and More

Stocks were indicated up sharply on Thursday morning as China banned large stakeholders and insiders from selling shares in an effort to stop the sell-off. Yet again, the trend that ...
Read Full Story »

4 Fresh Biotech Stock Picks With Targets 50% to 100% Higher

If one area has been a standout sector in the bull market, it is biotechnology and the areas surrounding it. 24/7 Wall St. is not alone in being amazed at just ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Garmin, IMAX, Micron, Kimberly-Clark, P&G and More

Stocks were looking for direction on Thursday morning ahead of the three-day weekend. The six-year-old bull market may have stalled in the first quarter, but the one trend that has ...
Read Full Story »
Active investor

Volatile Market Week Doesn’t Stop Insiders From Buying Stock

With January coming to an end, investors may be more than ready to see February. With all the major indexes likely to end the month in the red, and volatility ...
Read Full Story »